EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 138 filers reported holding EPIZYME INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $334,000 | +15.6% | 20,812 | +11.7% | 0.02% | -5.3% |
| Q1 2020 | $289,000 | -21.7% | 18,633 | +24.2% | 0.02% | +35.7% |
| Q4 2019 | $369,000 | +5171.4% | 15,003 | +2037.2% | 0.01% | – |
| Q3 2019 | $7,000 | -99.2% | 702 | -99.0% | 0.00% | -100.0% |
| Q2 2019 | $912,000 | +7500.0% | 72,700 | +7593.1% | 0.04% | +4400.0% |
| Q1 2019 | $12,000 | +71.4% | 945 | -21.1% | 0.00% | – |
| Q4 2018 | $7,000 | +16.7% | 1,198 | +115.5% | 0.00% | – |
| Q3 2018 | $6,000 | -98.5% | 556 | -97.6% | 0.00% | -100.0% |
| Q1 2017 | $399,000 | +17.0% | 23,243 | -17.6% | 0.04% | -7.3% |
| Q4 2016 | $341,000 | +432.8% | 28,222 | +730.1% | 0.04% | +355.6% |
| Q1 2015 | $64,000 | -61.4% | 3,400 | -61.4% | 0.01% | -64.0% |
| Q4 2014 | $166,000 | +11.4% | 8,800 | +60.0% | 0.02% | +19.0% |
| Q3 2014 | $149,000 | +272.5% | 5,500 | +323.1% | 0.02% | +320.0% |
| Q2 2014 | $40,000 | -48.1% | 1,300 | -61.8% | 0.01% | -50.0% |
| Q1 2014 | $77,000 | – | 3,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |